IRAK4-IN-7 is a selective, potent and orally active interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, extracted from patent WO2015104688 (example 1). IRAK4-IN-7 has the potential for cancer and inflammatory diseases treatment[1].
Molecular Weight:
417.42
Purity:
99.36
CAS Number:
[1801343-74-7]
Formula:
C21H19N7O3
Target:
IRAK
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted